Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet delivery technology. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T... Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet delivery technology. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumours. Show more
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc. PR Newswire SAN DIEGO, Nov. 26, 2024 Poseida stockholders to receive up to $13.00 per share in cash...
Poseida Therapeutics Hosts Cell Therapy R&D Day Highlighting Its Innovative Clinical and Preclinical Pipeline PR Newswire SAN DIEGO, Nov. 14, 2024 Emerging leadership in allogeneic CAR-T for...
Poseida Therapeutics to Present at Two Upcoming Investor Conferences PR Newswire SAN DIEGO, Nov. 11, 2024 SAN DIEGO, Nov. 11, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a...
Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2024 PR Newswire SAN DIEGO, Nov. 7, 2024 Strong collaboration momentum with Roche expansion of CAR-T...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 6.62 | 246.096654275 | 2.69 | 9.42 | 2.69 | 8269798 | 9.24959661 | CS |
| 4 | 6.91 | 287.916666667 | 2.4 | 9.42 | 2.39 | 2220801 | 7.90770446 | CS |
| 12 | 6.55 | 237.31884058 | 2.76 | 9.42 | 2.32 | 1033896 | 6.33927178 | CS |
| 26 | 6.52 | 233.691756272 | 2.79 | 9.42 | 2.32 | 698260 | 5.29507469 | CS |
| 52 | 6.65 | 250 | 2.66 | 9.42 | 1.91 | 762133 | 4.11658023 | CS |
| 156 | 2.29 | 32.6210826211 | 7.02 | 9.42 | 1.54 | 676773 | 3.82714293 | CS |
| 260 | -7.69 | -45.2352941176 | 17 | 17.62 | 1.54 | 551638 | 4.88856116 | CS |
| Symbole | Prix | Vol. |
|---|---|---|
| IXUSiShares Core MSCI Total International Stock | US$ 68,8633 (-0,40%) | 8,1M |
| VIRXViracta Therapeutics Inc | US$ 0,172 (21,90%) | 1,58M |
| RGTIRigetti Computing Inc | US$ 3,07 (0,66%) | 508,8k |
| SGBXSafe and Green Holdings Corporation | US$ 0,8891 (81,45%) | 486,37k |
| TSDDGraniteShares ETF Trust GraniteShares | US$ 2,56 (0,00%) | 450,11k |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
